Q3 Korean Biotech Roundup: Eyes On Orum's IPO Plan

HLB Resubmits HCC Combo In US

 
• By Jung Won Shin
  
IPO
Orum Says Market Conditions Turn More Favorable For An IPO • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia